For years, genetic studies have been churning out lists of DNA variants associated with chronic pain. Great, fantastic, here are 87 spots in the genome that seem to matter. But here's the problem nobody likes to talk about: knowing a variant's address doesn't tell you what house it lives in. It's like getting coordinates for a party but not knowing if you're looking for an apartment, a warehouse, or a boat.
A study in the Journal of Clinical Investigation finally provides the missing context. By combining genetic data with single-cell information from human brains and dorsal root ganglia, researchers have mapped which actual cell types carry the genetic burden for chronic pain. Spoiler: it's not just the obvious "ouch" neurons.
Surprise! Pain Lives in Your Emotional Brain
When the researchers looked at which brain cells were enriched for chronic pain genetic variants, the results were genuinely interesting. The usual suspects showed up, sure, but so did some unexpected guests.
The winning cell types were glutamatergic (excitatory) neurons, particularly in the prefrontal cortex, hippocampal CA1-3 regions, and amygdala. If you're thinking "wait, aren't those the areas for thinking, memory, and emotions, not pain?" then congratulations, you've identified exactly why this matters.
Pain isn't just a sensation. Anyone who's experienced chronic pain already knows this. It's wrapped up in memory (your brain remembers and anticipates pain), emotion (pain makes you miserable and anxiety makes pain worse), and cognition (pain is exhausting and hard to ignore). The genetics are now confirming what patients have been saying all along: chronic pain is a whole-brain experience, not just a sensory signal running from point A to point B.
Meanwhile, in Your Spine's Waiting Room
But let's not forget the periphery. The dorsal root ganglia (DRG) are clusters of sensory neurons sitting just outside your spinal cord like a reception desk. They're the first stop for sensory information coming from your body, including pain signals.
In these neurons, the researchers found strong enrichment for pain variants in a specific subtype with the unwieldy name hPEP.TRPV1/A1.2. These are almost certainly nociceptors, the neurons that actually detect painful stimuli at the body's surface.
So chronic pain genetics points to both the detectors ("hey, that hurts!") and the processors ("and now I'm going to think about how much that hurt for the next six hours"). It's a distributed problem, which explains why chronic pain is so maddeningly difficult to treat.
Opening the Right Books in the DNA Library
The team also examined chromatin accessibility, which is a fancy way of asking: which parts of the DNA instruction manual are actually open and readable in different cell types? Think of your genome as a massive library where most books are locked away. Only certain books are accessible in each cell type, and that determines what genes that cell can use.
In the brain, both excitatory and inhibitory neocortical neurons showed enrichment for pain-associated variants in their "open" DNA regions. In the mouse dorsal horn (where pain signals first get processed in the spinal cord), midventral neurons and oligodendrocyte precursor cells were implicated.
Wait, oligodendrocyte precursors? Those are the cells that produce myelin, the insulation around nerve fibers. Their appearance in a pain study is unexpected and hints that the supporting cast of cells, not just neurons, might play a role in chronic pain biology. Something to keep an eye on.
The Usual Suspects Bring Some New Friends
When the researchers zoomed in on specific genes and pathways, some familiar characters emerged: kinase activity, GABAergic synapses, axon guidance, and neuron projection development in the brain. In the DRG, glutamatergic signaling and neuronal projection genes were implicated.
But the gene-level analysis also highlighted some specific players worth remembering:
- EFNB2: involved in cell signaling and axon guidance
- GABBR1: a GABA receptor, suggesting inhibitory signaling matters
- NCAM1: a cell adhesion molecule, hinting at structural organization
- SCN11A: a sodium channel gene already known to cause pain disorders when mutated
These emerged from comparing acute versus chronic pain samples in the DRG, suggesting they might be particularly relevant for the transition from temporary pain to the persistent kind that ruins lives.
Why We Should Care About Cell Types
Here's where this gets practical. Current pain treatments are about as targeted as throwing a bucket of water at a candle factory and hoping you hit the right flame. Opioids? They affect the entire nervous system (and plenty of other systems too). NSAIDs? They reduce inflammation everywhere. Gabapentinoids? They dampen neural excitability broadly.
These approaches work for some people, partially, with side effects. What if we could instead target just the specific neuron types that carry the genetic risk for chronic pain?
If the prefrontal cortex glutamatergic neurons are involved, maybe treatments could target their specific receptor subtypes. If the hPEP.TRPV1/A1.2 neurons in the DRG are key players, drugs could potentially be designed to affect only those cells. This is the promise of precision medicine applied to pain: understanding the biology at the cellular level so treatments can be specific rather than sledgehammer-like.
The Bottom Line
Chronic pain isn't monolithic. It emerges from a distributed network of cells, both in the brain's emotional and cognitive regions and in the sensory neurons of the peripheral nervous system. Now we have a map showing which cell types carry the genetic burden.
This is exactly the kind of basic science work that eventually leads to better treatments. First, you figure out what's actually broken. Then, you can start thinking about how to fix it.
Precision pain medicine might still be years away, but at least we finally have the right address book.
Reference: Toikumo S, et al. (2025). The cell-type-specific genetic architecture of chronic pain in brain and dorsal root ganglia. Journal of Clinical Investigation. doi: 10.1172/JCI197583 | PMID: 41055971
Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.